Michael Welsh | Genetics and Molecular Biology | Best Researcher Award

Prof. Michael Welsh |Genetics and Molecular Biology | Best Researcher Award

Uppsala University, Sweden

Professor J. Michael Welsh is an internationally recognized biomedical scientist renowned for his pioneering research in the field of medical cell biology, particularly focusing on cystic fibrosis, epithelial ion transport, and pulmonary disease mechanisms. As a leading figure in translational medicine, Professor Welsh has made groundbreaking discoveries that have reshaped the global understanding of cystic fibrosis pathophysiology, contributing directly to the development of therapeutic strategies that have improved patient outcomes worldwide. His research has centered on the molecular and cellular basis of epithelial ion channel dysfunction, elucidating the mechanisms by which CFTR gene mutations cause abnormal chloride transport and disrupted mucociliary clearance in the airways. Throughout his distinguished career, Professor Welsh has authored over 610 peer-reviewed publications, accumulating more than 62,725 citations and achieving an h-index exceeding 130, underscoring his far-reaching influence in the biomedical community. His scholarly excellence and innovation have earned him election to the U.S. National Academy of Sciences and the National Academy of Medicine, reflecting his standing as one of the foremost authorities in molecular physiology and genetics. In addition to his scientific achievements, Professor Welsh has demonstrated exemplary leadership as the founder of the University of Iowa Cystic Fibrosis Research Center, fostering cross-disciplinary collaborations with clinicians, geneticists, and pharmaceutical scientists to accelerate the translation of basic research into clinical applications. Professor Welsh’s research has profoundly influenced not only molecular medicine but also public health, by shaping therapeutic approaches that extend life expectancy and quality of life for individuals affected by genetic and respiratory diseases. His mentorship of emerging scientists and his commitment to collaborative, patient-centered innovation exemplify his enduring contribution to science and society. Through his visionary work, Professor Welsh continues to bridge the gap between molecular discovery and clinical transformation, embodying the essence of global scientific excellence and impact.

Profiles: Scopus | ORCID

Featured Publications

  1. Celis, N., Miller, D. P., Tarara, T. E., Weers, J. G., Thornell, I. M., Welsh, M. J., & Burke, M. D. (2025). Molecular prosthetics and CFTR modulators additively increase secretory HCO3− flux in cystic fibrosis airway epithelia. bioRxiv.

  2. Welsh, M. J. (2025, September 11). Rewriting the chapter on cystic fibrosis. JAMA.

  3. Welsh, M. J. (2025, August 10). A dose-finding study shows terazosin enhanced energy metabolism in neurologically healthy adults. Journal of Parkinson’s Diseases.

  4. Thornell, I. M., Lei, L., McCray, P. B. Jr., & Welsh, M. J. (2025). Do pulmonary ionocytes absorb chloride or secrete chloride? American Journal of Physiology-Cell Physiology.

  5. Karp, P., Welsh, M., Kim, B. R., Keen, H., Rauckhorst, A. J., Taylor, E. B., Chimenti, M. S., & Rehman, T. (2025, January 24). The oxygen level in air directs airway epithelial cell differentiation by controlling mitochondrial citrate export. Science Advances.

Professor Michael Welsh’s work has revolutionized the understanding and treatment of cystic fibrosis by uncovering the molecular mechanisms of CFTR dysfunction, leading to life-changing therapies for patients worldwide. His groundbreaking research bridges molecular biology and clinical medicine, driving global innovation in genetic disease treatment and advancing precision healthcare.

Prof. Tian-yun Wang | Genetics and Molecular Biology | Scientific Excellence Achievement Award

Prof. Tian-yun Wang | Genetics and Molecular Biology | Scientific Excellence Achievement Award

Henan Medical University, China

Prof. Tianyun Wang is a renowned Professor in the Department of Biochemistry and Molecular Biology at Xinxiang Medical University, China, recognized for his pioneering contributions to molecular genetics and recombinant protein engineering. He holds a Ph.D. in Genetics from Zhengzhou University (2005), a Master’s degree in Biochemical Engineering from Shanghai University (2001), and a Bachelor’s degree in Biological Education from Qufu Normal University (1993). With over two decades of academic and research excellence, Prof. Wang has served as Professor and Deputy Director at Xinxiang Medical University since 2012, following earlier roles as Associate Professor and Lecturer. His professional expertise lies in cellular bioengineering, molecular genetics, and protein expression, particularly in advancing recombinant protein production in Chinese Hamster Ovary (CHO) cells—a cornerstone in modern biopharmaceutical development. Prof. Wang’s research interests include genetic regulation, molecular cloning, and the biotechnological enhancement of therapeutic protein yield and quality. His technical proficiency encompasses advanced cell culture systems, gene editing, molecular modeling, and bioinformatics analysis, reflecting a strong command of both experimental and computational tools. With 170 publications, 2,513 citations, and an h-index of 24, his scholarly output underscores his global influence and sustained scientific innovation. His honors include the Scientific Innovation Talent Award (2015), Outstanding Teacher Award (2012), and multiple provincial science and technology prizes, reflecting his excellence in both research and education. Prof. Wang has successfully led numerous nationally funded research projects, contributing significantly to China’s biotechnological advancement. His academic leadership, research acumen, and mentorship have shaped many young scientists in molecular life sciences. In conclusion, Prof. Tianyun Wang stands as a distinguished scholar whose visionary research and commitment to innovation continue to bridge molecular biology and industrial biotechnology, driving forward advancements in recombinant protein production and contributing meaningfully to global biomedical science.

Profiles: Scopus | ORCID

Featured Publications

  1. Han, Z., Han, X., Cheng, W., Geng, S., Li, W., Wang, T., & Wang, X. (2025). Application of transposon expression system in recombinant protein expression and gene therapy. Biochimie.

  2. Geng, S., Zou, Y., Bai, Z., Zhang, M., Wang, C., & Wang, T. (2025). Serum‐free medium for recombinant protein expression in insect cells. Biotechnology and Applied Biochemistry.

  3. Yuan, J., Geng, S., & Wang, T. (2025). Research progress fusion tags for recombinant protein production. Biotechnology and Applied Biochemistry.

  4. Wang, C., Guo, X., Wang, W., Li, J. X., & Wang, T. (2025). From cell clones to recombinant protein product heterogeneity in Chinese hamster ovary cell systems. International Journal of Molecular Sciences, 26(3), 1324.

  5. Fu, Y., Han, Z., Cheng, W., Niu, S., Wang, T., & Wang, X. (2024). Improvement strategies for transient gene expression in mammalian cells. Applied Microbiology and Biotechnology.

Prof. Tianyun Wang’s work significantly advances global biopharmaceutical innovation through cutting-edge research in recombinant protein engineering and molecular genetics. His contributions enhance the efficiency of therapeutic protein production, bridging scientific discovery with industrial biotechnology to improve healthcare and promote sustainable biomedical development worldwide.

Peter Poczai | Plant Genetics | Best Researcher Award

Assoc. Prof. Dr. Peter Poczai | Plant Genetics | Best Researcher Award

University of Helsinki | Finland

Assoc. Prof. Dr. Peter Poczai is a distinguished researcher and academic leader in the fields of plant systematics, museomics, phylogenomics, and evolutionary biology. He earned his Ph.D. in Agricultural Sciences (Plant Genetics) from Georgikon, Hungary, followed by habilitation in Biological Sciences and a docentship in Plant Systematics at the University of Helsinki, where he currently serves as Associate Professor and Scientific Authority (Plants) for CITES Finland. His professional experience includes leading international research projects funded by the EU and the Academy of Finland, with visiting fellowships at Radboud University, the Royal Botanical Garden Edinburgh, and the Institute of Advanced Studies, Hungary. His research interests focus on applying genomic tools and museum collections to study plant evolution, invasive species, and climate change impacts, while his skills extend to molecular biology, bioinformatics, conservation policy, and development of scientific software tools such as IRscope and Chloroplot. He has published over 150 peer-reviewed articles in top journals, authored textbooks and the widely acclaimed book Heredity Before Mendel, and serves as Associate Editor for Frontiers in Genetics and Ecology and Evolution. Recognized with fellowships and leadership roles, his awards and honors reflect global contributions to biodiversity science. In conclusion, Dr. Poczai exemplifies academic excellence, innovative research, and impactful conservation leadership, bridging science, policy, and public engagement.

Profile: Scopus

Featured Publications

  • Kantelinen, A., Printzen, C., Poczai, P., & Myllys, L. (2022). Lichen speciation is sparked by a substrate requirement shift and reproduction mode differentiation. Scientific Reports, 12(1), Article 11048. doi:10.1038/s41598-022-14970-9 (7)

  • Cseh, A., Poczai, P., Kiss, T., Balla, K., Berki, Z., Horváth, Á., Kúti, C., & Karsai, I. (2021). Exploring the legacy of Central European historical winter wheat landraces. Scientific Reports, 11, Article 23915. doi:10.1038/s41598-021-03261-4 (13)

 

Muhammad Farhat Ullah | Genetics and Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Muhammad Farhat Ullah | Genetics and Molecular Biology | Best Researcher Award

University of Sialkot | Pakistan

Assist. Prof. Dr. Muhammad Farhat Ullah is a highly accomplished researcher and academic specializing in bioinformatics, molecular biology, forensic genomics, and population genetics. With over eight years of teaching and research experience, he has developed a reputation as an innovative scientist and dedicated mentor. He earned his Ph.D. in Bioinformatics from Quaid-i-Azam University Islamabad, where his research focused on genetic variability, population genomics, and computational biology. Currently serving as an Assistant Professor at the University of Sialkot (USKT), he combines advanced computational techniques with experimental biology to solve pressing biological and forensic problems. Dr. Ullah has made significant contributions to scientific literature with more than twenty peer-reviewed publications in prestigious journals indexed in Scopus and Web of Science. His works span diverse areas, including Y-STR mutation analysis, nanotechnology applications in biomedical sciences, population structure studies, and computational approaches to drug discovery. International collaborations with research groups in Italy, China, and the UAE highlight his global research presence. In addition to his scientific contributions, Dr. Ullah plays an active role in departmental leadership as Secretary of multiple academic committees and serves as a mentor for graduate and undergraduate students, promoting research excellence and innovation.

Professional Profile

Education

Assist. Prof. Dr. Muhammad Farhat Ullah academic journey reflects a consistent pursuit of excellence and interdisciplinary expertise. He began his higher education with a Bachelor of Science degree in Biotechnology from Gomal University, Dera Ismail Khan, Pakistan. During his undergraduate studies, he developed a strong foundation in molecular biology, genetics, and laboratory research techniques. He then pursued his Master of Science in Biotechnology at the International Islamic University Islamabad, where his thesis work focused on rationalization of pharmacotherapy in infectious diseases, giving him exposure to molecular diagnostics and applied biotechnology. Building upon this, he advanced to doctoral studies at Quaid-i-Azam University Islamabad, one of Pakistan’s leading research institutions. He completed his Ph.D. in Bioinformatics, with a dissertation centered on population genetics, mutational analysis of rapidly mutating Y-STRs, and computational biology approaches to genomic studies. His doctoral research combined statistical modeling, bioinformatics tools, and molecular analysis to address population-level genetic variations with forensic and biomedical implications. Throughout his academic career, Dr. Ullah has consistently demonstrated interdisciplinary expertise, blending wet-lab techniques with computational genomics. His educational achievements reflect a strong progression from biotechnology fundamentals to advanced computational bioinformatics, positioning him as a well-rounded scholar in life sciences.

Professional Experience

Assist. Prof. Dr. Muhammad Farhat Ullah currently serves as an Assistant Professor in the Department of Biological Sciences at the University of Sialkot, Pakistan. In this role, he teaches undergraduate and graduate courses in bioinformatics, molecular biology, and biotechnology, while supervising multiple MS and BS research theses. His teaching portfolio includes advanced bioinformatics, industrial biotechnology, biosafety, recombinant DNA technology, synthetic biology, and computational biology. Prior to his current role, Dr. Ullah worked as a Research Assistant and committee member at Quaid-i-Azam University Islamabad, where he gained hands-on experience with DNA extraction, PCR, gel electrophoresis, protein modeling, and next-generation sequencing analysis. He has also collaborated with international institutions on population genetics projects, including the Sapienza University of Rome in Italy, research centers in China, and police forensic units in Dubai. Beyond teaching and research, he holds leadership roles as Secretary of the Board of Studies, Curriculum Review Committee, and Industrial Advisory Board at USKT. His professional journey demonstrates a balance of academic instruction, research innovation, and administrative leadership. Through active mentorship, he is contributing to the development of the next generation of scientists while continuing to expand his global research collaborations.

Research Interests

Assist. Prof. Dr. Muhammad Farhat Ullah’s research interests are broad yet interconnected, reflecting his interdisciplinary training in biotechnology and bioinformatics. His primary focus lies in forensic genomics, where he investigates rapidly mutating Y-STRs and their applications in population genetics and forensic casework. He has contributed to understanding genetic diversity in Pakistani populations and collaborated with international groups to study Kohistani and Gilgiti populations, enhancing knowledge of South Asian genetic history. In addition, he explores bioinformatics-driven approaches for drug discovery and development, employing computational tools to model proteins, analyze mutations, and identify molecular targets. His work also extends to nanotechnology, where he evaluates nanoparticles and nanocomposites for biomedical and environmental applications, such as photocatalysis and drug delivery. Dr. Ullah has also been actively engaged in pandemic-related research, including the use of CRISPR/Cas9 technology in COVID-19 treatment strategies. He is equally passionate about population genomics, mitochondrial genomics, and exome sequencing, integrating advanced statistical methods with molecular data. His multidisciplinary research interests demonstrate his commitment to applying computational biology in solving real-world problems in healthcare, forensic science, and environmental sustainability. This fusion of molecular experimentation and computational analysis positions him at the cutting edge of modern life sciences research.

Research Skills

Assist. Prof. Dr. Muhammad Farhat Ullah possesses a diverse skill set that integrates both laboratory-based molecular biology techniques and advanced computational bioinformatics tools. His experimental expertise includes DNA extraction, PCR amplification, gel electrophoresis, polyacrylamide gel electrophoresis, Sanger sequencing, and capillary electrophoresis using Applied Biosystems Genetic Analyzers (310 and 3100). He is skilled in STR biomarker analysis, including Y-STRs and rapidly mutating STRs, which are widely applied in forensic genetics and population studies. On the computational side, he has extensive experience with whole exome sequencing analysis, protein modeling, primer designing, and in-silico mutational analysis. He is proficient in statistical data analysis using MATLAB (R2022b) and multiple bioinformatics software platforms for gene scanning, genotyping, and protein structure evaluations. His technical expertise further extends to nanotechnology characterization techniques, computational drug discovery, and modeling of genetic variations. In addition, Dr. Ullah has strong skills in teaching and mentoring, supervising student projects involving computational genomics, SNP analysis, and phylogenetic studies. His ability to bridge wet-lab and dry-lab skills makes him a versatile scientist, capable of handling diverse research projects. By combining hands-on experimental knowledge with computational proficiency, Dr. Ullah contributes to advancing molecular biology, forensic science, and biomedical applications.

Awards and Honors

Assist. Prof. Dr. Muhammad Farhat Ullah has received recognition for his academic achievements, research contributions, and leadership roles. During his Ph.D., he was awarded the prestigious IRSIP fellowship by the Higher Education Commission (HEC) of Pakistan, which enabled him to undertake an international research internship at the Sapienza University of Rome, Italy. This fellowship provided him with exposure to cutting-edge genetic research methodologies and allowed him to collaborate with world-renowned population geneticists. At the University of Sialkot, he has been entrusted with significant academic leadership responsibilities, including serving as Secretary of the Board of Studies, Curriculum Review Committee, and Industrial Advisory Board within the Department of Biological Sciences. His professional achievements also include active participation in international collaborations with institutions in China, Dubai, and Italy, contributing to projects on population genetics, forensic applications of Y-STRs, and mitochondrial genomics. In addition to formal recognition, he has built a strong publication record in high-impact journals, which reflects his growing influence in the scientific community. These achievements, coupled with his dedication to student mentorship and research advancement, demonstrate his standing as an emerging leader in bioinformatics and molecular genetics at both national and international levels.

Publication Top Notes

  • Population and mutational assessment of novel repeats in 13RM Y-STRs in unrelated males born in Gilgit, Pakistan — 2022

  • Novel heterozygous frameshift mutation in distal-less homeobox 5 underlies isolated split hand/foot malformation type 1 — 2016

  • Evaluation of rapidly mutating Y-STRs in Pakistani population — 2019

  • A review of COVID-19: Treatment strategies and CRISPR/Cas9 gene editing technology approaches to the coronavirus disease — 2021

  • Biosynthesis of silver nanoparticles from novel Bischofia javanica plant loaded chitosan hydrogel: as antimicrobial and wound healing agent — 2022

  • Structural Evaluation and Conformational Dynamics of ZNF141T474I Mutation Provoking Postaxial Polydactyly Type A — 2022

  • RM-plex kit to analyze 130 father-son pairs from Gilgit Baltistan region of Pakistan at 13 RM Y-STR loci, producing unique mutation data and merging it with previously reported mutation data.

Conclusion

In conclusion, Assist. Prof. Dr. Muhammad Farhat Ullah exemplifies the qualities of an outstanding researcher, academic leader, and mentor. His educational foundation in biotechnology and bioinformatics, coupled with his extensive research in forensic genomics, computational biology, and nanotechnology, positions him as a versatile and impactful scholar. With more than twenty international publications, several collaborative projects, and active involvement in student supervision, he has significantly contributed to advancing knowledge in population genetics, forensic casework, and biomedical applications. His IRSIP fellowship experience in Italy and collaborations with global institutions reflect his ability to integrate international expertise into local research contexts, thereby strengthening Pakistan’s presence in the global scientific arena. Dr. Ullah’s technical proficiency, innovative research approaches, and dedication to teaching make him a role model for aspiring scientists. Moving forward, his commitment to expanding Q1 publications, engaging in editorial responsibilities, and pursuing broader global collaborations will further enhance his academic footprint. With proven leadership at his institution and a growing international reputation, Dr. Ullah has the potential to become a leading figure in bioinformatics and molecular sciences. His contributions to science and education make him a deserving candidate for recognition at the international level.

Baran Seven | Molecular Biology | Best Researcher Award

Dr. Baran Seven | Molecular Biology | Best Researcher Award

Researcher in Biotechnology from TST Fittings and Medical Devices Industry and Trade Ltd Co | Turkey

Dr. Baran Seven is a highly dedicated and accomplished researcher in the field of Biology, with a specialization in toxicology, genotoxicology, and environmental biology. He holds a Ph.D. from Giresun University and has devoted his academic career to exploring the physiological, genetic, and biochemical impacts of various toxic agents using experimental models such as albino mice and Allium cepa root tips. His research is particularly focused on understanding the damage caused by environmental pollutants like cypermethrin, parabens, and heavy metals, as well as investigating the protective roles of natural substances such as Urtica dioica and Nigella sativa. Dr. Seven has been involved in numerous national research projects and has published extensively in both national and international journals, including Scientific Reports and Global NEST. He has presented his work at significant scientific conferences, demonstrating his commitment to knowledge dissemination and academic engagement. With a strong background in experimental toxicology and molecular biology, he continues to contribute meaningful insights to the understanding of environmental health risks. His work is relevant to public health, food safety, and environmental protection, making him a valuable asset to the academic and scientific community in Turkey and beyond.

Professional Profile

Education

Dr. Baran Seven’s academic journey began with a Bachelor’s degree in Biology from Giresun University in 2013. He continued his education in the same institution, completing a Master’s degree in 2015 under the Department of Biology. His MSc thesis explored the protective effects of Urtica dioica (nettle extract) against paraben-induced toxicity in albino mice, under the supervision of Assoc. Prof. Dr. Kültiğin Çavuşoğlu and Prof. Dr. Kürşad Yapar. This early research laid the foundation for his long-term interest in natural protectants against environmental toxins. In 2022, Dr. Seven earned his Ph.D. in Biology from Giresun University. His doctoral thesis, supervised by Prof. Dr. Kültiğin Çavuşoğlu, was titled “Investigation of Cypermethrin Toxicity in Swiss Albino Mice: A Physiological, Genetic and Biochemical Approach.” This work involved the use of sophisticated assays to analyze the effects of cypermethrin, a widely used pesticide, highlighting his expertise in interdisciplinary methods. Throughout his academic career, Dr. Seven has displayed consistent scholarly growth, choosing thesis topics that reflect emerging concerns in toxicology and environmental biology. His education has equipped him with both theoretical knowledge and practical research skills in molecular, biochemical, and physiological domains of biology.

Professional Experience

Dr. Baran Seven has accumulated substantial professional experience as a biologist and academic researcher. Throughout his academic trajectory at Giresun University, he has contributed to various scientific investigations and served as a research assistant or contributing scientist in several funded projects. His roles have included conducting laboratory experiments, analyzing toxicological effects, and validating findings using established molecular and biochemical protocols. Among the research projects he contributed to are investigations on the physiological and genotoxic effects of ultraviolet radiation on Allium cepa root tip cells and the protective roles of compounds like carotene and black seed (Nigella sativa) against lead and ammonium sulfate-induced toxicity. He has taken part in both experimental design and data interpretation phases, demonstrating his comprehensive involvement. Dr. Seven’s conference participation also speaks to his professional engagement, as he has presented findings at multiple international and national scientific gatherings. These experiences have enabled him to collaborate with academic peers, refine his methodologies, and gain valuable insights into global environmental health issues. His continuing research and scholarly output reflect an integrated and expanding professional portfolio grounded in experimental toxicology, environmental biology, and molecular diagnostics.

Research Interest

Dr. Baran Seven’s research interests are centered on toxicology, genotoxicity, oxidative stress mechanisms, and the application of natural extracts for therapeutic purposes. He is particularly interested in understanding how environmental pollutants such as pesticides (e.g., cypermethrin), industrial chemicals (e.g., parabens), and heavy metals (e.g., lead, lithium, titanium dioxide) interact with living organisms at the genetic, cellular, and systemic levels. His work employs both in vivo models (notably albino mice) and plant-based systems (e.g., Allium cepa) to evaluate toxicity and its potential reversal using natural antioxidants. He investigates DNA damage using comet assays, chromosomal aberration tests, and other molecular techniques. A key area of his interest lies in evaluating the protective roles of natural substances, such as grape seed extract, green coffee, resveratrol, and Nigella sativa, against genotoxic stress. His aim is to identify safe, plant-based therapeutic alternatives for mitigating the harmful effects of various chemicals. His interdisciplinary approach combines biology, toxicology, pharmacology, and environmental science. This holistic research focus places Dr. Seven at the intersection of molecular biology and public health, addressing urgent concerns about food safety, environmental contamination, and sustainable chemical use.

Research Skills

Dr. Baran Seven possesses a well-developed skill set in molecular biology, toxicological assays, and biochemical analysis. He is proficient in various experimental techniques such as the comet assay for DNA damage detection, chromosomal aberration analysis, and micronucleus formation assays. These tools enable him to examine genotoxic effects at a molecular level. Additionally, he has expertise in biochemical assays to measure oxidative stress parameters, including enzymatic activity (e.g., catalase, SOD) and lipid peroxidation. His training also includes physiological assessments in model organisms like mice, evaluating weight change, organ histology, and behavioral responses to toxins. Dr. Seven is also skilled in plant-based bioassays, particularly using Allium cepa root tips to assess genotoxicity in environmental samples or chemical treatments. His data analysis capabilities include statistical evaluation using SPSS or similar platforms, and he is experienced in writing technical reports and scientific articles for peer-reviewed journals. He has also demonstrated his capabilities in research project planning and implementation, often collaborating with fellow researchers and supervisors to develop effective methodologies. His cumulative skill set makes him highly competent in conducting both laboratory-based and applied research in toxicology and environmental health.

Awards and Honors

While specific awards or honors are not explicitly listed, Dr. Baran Seven’s extensive contributions to nationally funded research projects, his publication in Scientific Reports (Nature group), and frequent conference presentations serve as significant academic distinctions. His active participation in over a dozen high-level scientific congresses and symposia—including IBCESS, Ecology Symposia, and Balkan International Applied Sciences Congress—highlights his continued recognition within the scientific community. He has also consistently collaborated with respected researchers such as Prof. Dr. Kültiğin Çavuşoğlu and has served as a lead or co-author in multiple peer-reviewed journals. His works have been published in high-impact platforms such as Global NEST Journal, Scientific Reports, and several Turkish Science Journals indexed in national databases. Presenting full-text studies at national and international congresses demonstrates not only his academic excellence but also his ability to communicate complex findings effectively to the scientific public. These achievements are indicative of an emerging academic with the potential for future honors, research fellowships, or international project leadership roles.

Publications Top Notes

  1. Investigation of cypermethrin toxicity in Swiss albino mice with physiological, genetic and biochemical approaches
  • Year: 2022

  • Citations: 25

Conclusion

Dr. Baran Seven is a committed and impactful researcher whose work bridges the fields of molecular toxicology, environmental health, and pharmacological protection. His contributions to understanding the physiological and genetic impact of chemical exposure—combined with his work on plant-based therapeutic interventions—underscore his value to both academia and public health. With more than 20 publications and numerous national research engagements, Dr. Seven has demonstrated both productivity and purpose in his scholarly journey. His commitment to environmentally safe science and health risk mitigation aligns with global research priorities, especially regarding sustainable living and food safety. With further global exposure and increased international collaboration, Dr. Seven is poised to emerge as a future leader in biological sciences and toxicology research. He is undoubtedly a deserving candidate for recognition under the International Research Awards, with a solid track record and clear potential for greater achievements.

XUEYING MAO | Biological Sciences | Best Researcher Award

Prof . XUEYING MAO | Biological Sciences | Best Researcher Award

Professor from China Agricultural University, China

Professor Xueying Mao is a distinguished academic and researcher at the College of Food Science and Nutritional Engineering, China Agricultural University. With over two decades of academic experience, she has built a strong profile in the field of dairy science, particularly in the study of milk fat globule membranes, food digestion, and nutritional bioactivity. Her scientific contributions have gained recognition through publications in top-tier journals like Trends in Food Science & Technology and Food Chemistry, where she has consistently served as the sole corresponding author. Professor Mao has shown a focused commitment to research that addresses the compositional and interfacial properties of milk, enhancing the understanding of dairy functionality and nutritional outcomes. She is currently a participating investigator in a major National Natural Science Foundation of China (NSFC) Key Project on ultra-high temperature sterilized milk proteins. Her long-standing academic involvement, rigorous scientific inquiry, and impactful publications have solidified her reputation as a leader in food science research. She has also made significant contributions to academic mentorship and the development of food technology education in China. Professor Mao’s work reflects both scientific depth and practical relevance, making her an exemplary candidate for prestigious recognitions such as the Best Researcher Award.

Professional Profile

Education

Professor Xueying Mao has pursued a progressive academic path with a strong foundation in both animal and food sciences. She earned her Bachelor’s degree in Animal Nutrition from Hebei Agricultural University in 1993, where she began her early academic engagement in nutritional studies. Continuing her academic journey, she obtained a Master’s degree in Animal Nutrition from Huazhong Agricultural University in 1996, developing deeper expertise in the biological and nutritional sciences of livestock and food production. She culminated her formal academic training with a Ph.D. in Food Science and Engineering from China Agricultural University in 2003. Her doctoral studies marked a transition into the food science discipline, integrating her background in animal nutrition with modern food processing and biochemical research. To further enhance her research capabilities, she completed a postdoctoral fellowship at Peking University from 2003 to 2005, where she likely broadened her interdisciplinary exposure and laboratory experience. This blend of education across different institutions and specialties has provided Professor Mao with a comprehensive understanding of food and nutritional sciences, from fundamental animal-based studies to advanced food engineering. Her educational background has laid a robust scientific and technical foundation for her extensive research career in dairy and nutritional engineering.

Professional Experience

Professor Xueying Mao has accumulated extensive professional experience in academia and research, marked by a steady progression through teaching and research roles. Her professional journey began in 1996 at the College of Animal Science and Technology, Hebei Agricultural University, where she served as a Lecturer. During this period, she focused on teaching and foundational research in animal nutrition. In 2005, she joined the College of Food Science and Nutritional Engineering at China Agricultural University as an Associate Professor. Her appointment marked a significant transition into food science, allowing her to apply her background in animal nutrition to emerging topics in food digestion and dairy processing. In 2013, she was promoted to Full Professor, a role she continues to hold today. Her professional growth reflects a trajectory of increasing leadership, mentorship, and research responsibilities. Notably, Professor Mao has been actively involved in several national-level research projects and has led or co-authored numerous influential publications. Her long-term association with China Agricultural University, a leading institution in agricultural and food sciences, has allowed her to contribute substantially to academic development, curriculum design, and collaborative research. Her career exemplifies sustained academic excellence and dedication to advancing food science in China.

Research Interest

Professor Xueying Mao’s research interests lie at the intersection of dairy science, food chemistry, and nutritional bioengineering. She is particularly focused on the composition, structural behavior, and functional properties of milk fat globule membranes (MFGM). Her work investigates the differences between natural and processed milk, with special attention to how interfacial properties affect digestion, bioactivity, and overall health benefits. A core component of her research explores comparative lipid digestion and immunomodulatory effects between goat and cow milk, providing valuable insights for both nutritional science and the dairy industry. In recent years, she has delved into the mechanisms of protein complex formation during ultra-high temperature (UHT) treatment and how these changes influence the development of aged gels, which are relevant in food storage and processing. Her current involvement in a National Natural Science Foundation of China (NSFC) Key Project exemplifies her leadership in addressing fundamental questions in food biochemistry. Professor Mao’s research bridges basic scientific understanding with practical applications in dairy processing, human health, and food formulation. Her studies contribute to the development of more functional and digestible dairy products, and she remains committed to expanding knowledge on food interfaces, emulsions, and bioactive food components.

Research Skills

Professor Xueying Mao possesses a robust set of research skills that support her work in food science and dairy technology. She is highly proficient in proteomic analysis, biochemical characterization, and structural evaluation of food emulsions, particularly milk fat globule membranes (MFGM). Her ability to study interfacial behavior at the molecular level enables her to unravel complex digestion and bioactivity mechanisms of dairy products. Professor Mao is skilled in designing and conducting comparative digestion studies, in vitro simulations, and analyzing the impact of food processing techniques such as ultra-high temperature (UHT) treatment on protein-lipid complexes. Her scientific approach is systematic and interdisciplinary, integrating analytical chemistry, nutritional biology, and food engineering. She is adept at using modern laboratory instruments for mass spectrometry, chromatography, and advanced microscopy, enabling high-precision evaluations of food structure and functionality. In addition, she has extensive experience in scientific writing, journal publication, and grant proposal development. Her leadership in collaborative research projects also highlights her capabilities in project coordination, data interpretation, and academic mentoring. Overall, Professor Mao’s technical expertise and methodological rigor place her among the leading researchers in the field of food and nutritional sciences.

Awards and Honors

While specific named awards are not listed in the provided information, Professor Xueying Mao’s career achievements reflect substantial academic recognition through prestigious project involvement and high-impact publications. She is currently a principal participant in a Key Project funded by the National Natural Science Foundation of China (NSFC), which signifies a competitive and prestigious acknowledgment of her research capabilities at the national level. Her repeated role as the sole corresponding author in internationally renowned journals like Trends in Food Science & Technology and Food Chemistry demonstrates a high degree of academic leadership and international recognition. These roles are typically reserved for researchers who contribute significantly to experimental design, data interpretation, and manuscript preparation. Her promotion to Full Professor at China Agricultural University and her long-standing tenure at this elite institution also point to continued institutional trust and acknowledgment of her research excellence. Although no formal awards are explicitly mentioned, her scholarly impact, project leadership, and publication record collectively affirm her status as a highly respected researcher in her domain. Additional documented honors or recognitions, if available, would further reinforce her qualifications for high-level academic awards and honors.

Conclusion

Professor Xueying Mao stands out as a seasoned researcher whose contributions to dairy science and nutritional engineering are both scientifically significant and socially relevant. Her focused research on the behavior of milk fat globule membranes and lipid digestion addresses key challenges in food functionality, health impact, and industrial processing. With a strong academic background, leadership in national research initiatives, and a series of impactful publications as sole corresponding author, Professor Mao exemplifies the qualities of a high-caliber researcher. Her methodical approach to studying food structure and digestion bridges basic science and applied technology, supporting innovations in food design and public nutrition. Though there is room to enhance her profile through broader project leadership or increased industry collaboration, her consistent academic excellence and subject matter depth firmly establish her as a leading figure in her field. She is well-qualified for consideration for the Best Researcher Award, and her career trajectory continues to reflect a strong commitment to scientific advancement and academic service. With continued support and recognition, Professor Mao is poised to make even greater contributions to the advancement of food science and engineering in China and internationally.

Publications Top Notes

  1. Title: The effect of degree of esterification of pectin on the grainy properties of post-heated fermented milk
    Authors: Gao, Fei; Mao, Xueying; Wang, Pengjie; Song, Sijia; Li, Dongdong
    Journal: Food Hydrocolloids
    Year: 2025

  2. Title: Changes in the interfacial properties of camel milk fat globules induced by homogenization and thermal processing: Implications for digestive characteristics
    Authors: Jiang, Hui; Xu, Yunxuan; Chen, Gangliang; Mao, Xueying
    Journal: Food Chemistry
    Year: 2025

  3. Title: Camel milk endogenous peptides ameliorated hyperglycemia in high-fat diet-fed C57BL/6 J mice in association with modulation of gut microbiota and the IRS/Akt and JNK/p38 pathways
    Authors: Zheng, Qianwen; Chen, Gangliang; Mao, Xueying
    Journal: Food Research International
    Year: 2025

  4. Title: Preheating intensity affects the properties of age gelation formed in direct ultra-high-temperature skim milk
    Authors: Liu, Xiaohan; Gong, Han; Hu, Yifan; Ren, Fazheng; Mao, Xueying
    Journal: International Dairy Journal
    Year: 2025

  5. Title: The compositions of milk fat globule membrane determine the interfacial behavior, digestive properties, and bioactivities: Natural versus processed forms (Review)
    Authors: Ma, Zhiyuan; Gong, Han; Liu, Biao; Mao, Xueying
    Year: 2025
    Citations: 2

  6. Title: Corrigendum to “Differences in proteomic profiles and immunomodulatory activity of goat and cow milk fat globule membrane” Food Chemistry 455 (2024) 139885
    Authors: Jiang, Hui; Gong, Han; Li, Qin; Gao, Jingxin; Mao, Xueying
    Journal: Food Chemistry (Corrigendum)
    Year: 2025

Sayan Chakraborty | Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Sayan Chakraborty | Molecular Biology | Best Researcher Award

Assistant Professor of Oncology from Roswell Park Comprehensive Cancer Center, United States

Dr. Sayan Chakraborty is an Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center, specializing in cancer biology and regenerative medicine. His research focuses on the role of extracellular matrix (ECM) proteins in cancer progression, particularly in liver cancer. With a strong background in microbiology, immunology, and cancer research, he has made significant contributions to understanding tumor microenvironments. Dr. Chakraborty has published extensively in high-impact journals, secured multiple research grants, and holds patents related to cancer diagnostics and therapies. He actively mentors Ph.D. students and postdoctoral researchers while serving on editorial boards of prestigious scientific journals. His work has been recognized through several national and international awards, including the A*STAR Career Development Award and Open Fund Young Investigator Grant. As an invited speaker at international conferences, he continues to shape the field of cancer research through his pioneering work in mechanotransduction and ECM-targeted therapies.

Professional Profile

Education

Dr. Chakraborty completed his Bachelor of Science (B.Sc.) in Zoology with honors from Presidency College, University of Calcutta, in 2006. He then pursued a Master of Science (M.Sc.) in Biochemistry at the University of Calcutta, graduating in 2008. His doctoral studies focused on the entry mechanisms of oncogenic human herpesvirus-8 (HHV-8/KSHV) and their role in Kaposi’s sarcoma development. He earned his Ph.D. from Rosalind Franklin University of Medicine and Sciences, USA, in collaboration with the Institute of Molecular and Cell Biology, Singapore. His postdoctoral training further refined his expertise in microbiology, immunology, and cancer research. With extensive training across renowned institutions in India, the USA, and Singapore, Dr. Chakraborty has built a strong foundation in cancer biology, extracellular matrix research, and mechanotransduction pathways in tumor progression.

Professional Experience

Dr. Chakraborty has held various research and academic positions across multiple prestigious institutions. He began his career as a Research Fellow at the Institute of Molecular and Cell Biology (IMCB), Singapore, in 2012. He was later promoted to Senior Research Fellow and then Research Assistant Professor at the same institute, focusing on cancer research and extracellular matrix dynamics. In 2022, he joined Roswell Park Comprehensive Cancer Center as an Assistant Professor of Oncology, where he is also a member of the Developmental Therapeutics Research Program. Additionally, he plays an active role in graduate education and experimental therapeutics programs. His research contributions extend beyond academia, as he serves as an editorial board member and peer reviewer for high-impact journals. His work in ECM-targeted cancer therapies and mechanotransduction has led to international recognition, positioning him as a key figure in oncology research.

Research Interests

Dr. Chakraborty’s research focuses on the role of extracellular matrix proteins in cancer progression and regenerative medicine. His laboratory investigates how tumor cells interact with ECM components, leading to changes in mechanotransduction pathways that drive oncogenic signaling. A major aspect of his work revolves around Agrin, a key ECM protein that promotes cancer progression through YAP/TAZ signaling and integrin-mediated mechanosensing. His studies explore how ECM-targeted strategies can disrupt tumor growth and angiogenesis, offering new therapeutic approaches for hepatocellular carcinoma and other cancers. Additionally, he is interested in the intersection of ECM biology and tissue regeneration, aiming to develop novel biomaterials for wound healing applications. His long-term research goal is to devise tumor-restraining strategies by targeting ECM components and their interactions with cancer cells, leading to more effective treatment options for patients.

Research Skills

Dr. Chakraborty has expertise in multiple advanced research methodologies, including molecular and cellular biology, cancer signaling, and mechanotransduction analysis. His laboratory specializes in ECM protein characterization, cancer cell migration assays, and 3D tumor modeling. He is proficient in high-resolution imaging techniques, such as confocal and electron microscopy, to analyze ECM-cancer interactions. Additionally, his skills in RNA sequencing, proteomics, and CRISPR-based gene editing allow for comprehensive molecular investigations in oncology. He has experience in preclinical cancer models, including xenograft and organoid systems, to study tumor microenvironments and evaluate potential therapeutics. His ability to integrate mechanobiology with cancer research has led to groundbreaking discoveries in ECM-targeted therapies. Beyond experimental techniques, he is skilled in grant writing, scientific publishing, and mentoring researchers, further contributing to the advancement of oncology research.

Awards and Honors

Dr. Chakraborty has received numerous accolades for his contributions to cancer research. He was awarded the Aparajita Memorial Gold Medallion for securing the first rank in his B.Sc. studies at Presidency College. He also received the CSIR-UGC Merit Scholarship and the University of Calcutta Foreign Scholarship for academic excellence. His doctoral work earned him the Dean’s Award for Outstanding Achievement in Research from Rosalind Franklin University. In Singapore, he was honored with the Early Career Research Award and the Open Fund Young Investigator Research Grant. His A*STAR Career Development Award recognized his pioneering work in ECM-targeted therapies. Recently, he secured the Cancer Center Support Grant at Roswell Park, further advancing his research into ECM and cancer therapeutics. These awards highlight his consistent excellence in research, funding acquisition, and scientific innovation.

Conclusion

Dr. Sayan Chakraborty is a leading researcher in cancer biology, with extensive contributions to understanding the extracellular matrix’s role in tumor progression. His research has led to the identification of ECM-targeted therapeutic strategies, with a particular focus on liver cancer. With a strong academic background, multiple international research experiences, and significant funding successes, he has established himself as a distinguished scientist in oncology. His mentorship, editorial roles, and extensive publication record further reflect his dedication to advancing cancer research. While his work is already making an impact, expanding clinical collaborations and large-scale translational studies could enhance the real-world applications of his findings. Dr. Chakraborty’s pioneering research, coupled with his leadership in the field, makes him a strong candidate for prestigious research awards and continued recognition in cancer biology.

Publications Top Notes

  1. Title: Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway
    Authors: S. Chakraborty, K. Njah, A. Pobbati, Y.B. Lim, A. Raju, M. Lakshmanan, …
    Year: 2017
    Citations: 225

  2. Title: Kaposi’s sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes
    Authors: V.V. Singh, N. Kerur, V. Bottero, S. Dutta, S. Chakraborty, M.A. Ansari, …
    Year: 2013
    Citations: 175

  3. Title: An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma
    Authors: S. Chakraborty, M. Lakshmanan, H.L.F. Swa, J. Chen, X. Zhang, Y.S. Ong, …
    Year: 2015
    Citations: 155

  4. Title: Kaposi’s sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection
    Authors: S. Chakraborty, M.V. Veettil, V. Bottero, B. Chandran
    Year: 2012
    Citations: 125

  5. Title: Kaposi’s sarcoma associated herpesvirus entry into target cells
    Authors: S. Chakraborty, M. Valiya Veettil, B. Chandran
    Year: 2012
    Citations: 110

  6. Title: Interaction of c-Cbl with Myosin IIA Regulates Bleb Associated Macropinocytosis of Kaposi’s Sarcoma-Associated Herpesvirus
    Authors: M.V. Veettil, S. Sadagopan, N. Kerur, S. Chakraborty, B. Chandran
    Year: 2010
    Citations: 82

  7. Title: Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival
    Authors: S. Sadagopan, M.V. Veettil, S. Chakraborty, N. Sharma-Walia, N. Paudel, …
    Year: 2012
    Citations: 73

  8. Title: Reactive oxygen species are induced by Kaposi’s sarcoma-associated herpesvirus early during primary infection of endothelial cells to promote virus entry
    Authors: V. Bottero, S. Chakraborty, B. Chandran
    Year: 2013
    Citations: 65

  9. Title: EphrinA2 regulates clathrin mediated KSHV endocytosis in fibroblast cells by coordinating integrin-associated signaling and c-Cbl directed polyubiquitination
    Authors: D. Dutta, S. Chakraborty, C. Bandyopadhyay, M. Valiya Veettil, M.A. Ansari, …
    Year: 2013
    Citations: 63

  10. Title: Linking extracellular matrix agrin to the hippo pathway in liver cancer and beyond
    Authors: S. Chakraborty, W. Hong
    Year: 2018
    Citations: 60

  11. Title: c-Cbl-Mediated Selective Virus-Receptor Translocations into Lipid Rafts Regulate Productive Kaposi’s Sarcoma-Associated Herpesvirus Infection in Endothelial Cells
    Authors: S. Chakraborty, M. Valiya Veettil, S. Sadagopan, N. Paudel, B. Chandran
    Year: 2011
    Citations: 54

  12. Title: The extracellular matrix in hepatocellular carcinoma: Mechanisms and therapeutic vulnerability
    Authors: A.M. Roy, R. Iyer, S. Chakraborty
    Year: 2023
    Citations: 47

Khalid Subhi Ibrahim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Assist. Prof. Dr. Khalid Subhi Ibrahim | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Followship at University of Zakho, United Kingdom

Dr. Khalid Subhi Ibrahim, an Assistant Professor at the University of Zakho, is a distinguished researcher in biomedical sciences, specializing in diagnostic and molecular microbiology, clinical biochemistry, and microbiome analysis. With a Ph.D. from Glasgow Caledonian University, his work focuses on understanding gut bacterial communities in obesity, Type 2 diabetes, and other health conditions using cutting-edge techniques like next-generation sequencing and bioinformatics tools such as QIIME2 and PICRUSt2. He has led significant collaborations, including projects with the Massachusetts Institute of Technology (MIT) and Kiel University, Germany, and has contributed to global microbiome conservancy efforts. An Editor-in-Chief of SJUOZ and a committee member of MVIF, Dr. Ibrahim’s expertise extends to training scientists, publishing research, and presenting at international conferences. His diverse contributions reflect his commitment to advancing microbiome research and its applications in health and environmental sciences.

Professional Profile

Education

Dr. Khalid Subhi Ibrahim holds a Ph.D. in Life Sciences from Glasgow Caledonian University, UK (2013-2017), where his research focused on “Biochemical Interactions Between the Gut Microbiome and Host in Obesity/Type 2 Diabetes.” He also completed an MSc in Veterinary Pathology specializing in fish diseases at the University of Duhok, Kurdistan Region, Iraq (2006-2008), presenting a thesis on pathological studies in common carp infected with Aeromonas hydrophila. Dr. Khalid earned his Bachelor of Veterinary Medicine (Medicine and Surgery) from the same institution in 2004. Additionally, he attended a Pre-sessional English Language program at Glasgow University in 2012. Throughout his education, Dr. Khalid developed extensive expertise in microbiology, molecular diagnostics, and bioinformatics. His academic foundation reflects a robust combination of veterinary science, microbiological research, and advanced molecular techniques, forming the basis of his prolific career in microbiome studies and biomedical sciences.

Professional Experience

Dr. Khalid Subhi Ibrahim is an accomplished Assistant Professor with extensive experience in biomedical sciences, specializing in diagnostic and molecular microbiology, clinical biochemistry, and gut microbiome research. He has a strong background in utilizing advanced molecular techniques such as next-generation sequencing, bioinformatics, and 16S rRNA analysis to explore microbiota in various contexts, including obesity, Type 2 diabetes, pollution, and animal health. Dr. Ibrahim has collaborated with prestigious institutions such as Glasgow Caledonian University, Monash University, MIT, and Universitätsklinikum Schleswig-Holstein on numerous international projects. His expertise extends to training scientists, supervising research students, and contributing to impactful research. Additionally, he has served as Editor-in-Chief of the SJUOZ journal and actively participated in global microbiome conservancy initiatives. With a proven track record of research, teaching, and collaboration, Dr. Ibrahim is dedicated to advancing microbiome science and fostering academic excellence.

Research Interest

Dr. Khalid Subhi Ibrahim’s research interests focus on biomedical sciences, with expertise in diagnostic and molecular microbiology, clinical biochemistry, and bioinformatics. His work centers on understanding the role of gut microbiome changes in health and disease, particularly in obesity, Type 2 diabetes mellitus (T2DM), and pollution. Employing advanced molecular techniques and next-generation sequencing, he investigates microbiota in humans, animals, soils, and wastewater, emphasizing 16S rRNA analysis using tools like QIIME2 and PICRUSt2. Dr. Ibrahim’s research extends to metagenomics and functional analysis of microbiomes in various contexts, including colorectal cancer, nosocomial infections in children, and zoonotic diseases in livestock. His collaborations span globally, engaging with institutions such as MIT, Universitätsklinikum Schleswig-Holstein, and the University of Tartu. Driven by a passion for microbiome research, he aims to advance in silico analysis techniques, enriching the understanding of microbial ecosystems and their impacts on human and environmental health.

Award and Honor

Dr. Khalid Subhi Ibrahim, a distinguished microbiologist and academic, has earned recognition for his remarkable contributions to biomedical sciences, particularly in microbiome research. Serving as Assistant Professor at the University of Zakho, Dr. Ibrahim leads the Global Microbiome Conservancy in Iraq and holds the prestigious position of Editor-in-Chief for the Scientific Journal of University of Zakho (SJUOZ). His collaborative endeavors span globally, involving partnerships with renowned institutions such as MIT, Universitätsklinikum Schleswig-Holstein, and Monash University. Dr. Ibrahim’s accolades include delivering impactful presentations at international conferences and publishing high-impact research on gut microbiota’s role in obesity, Type 2 diabetes, and pollution. His expertise in bioinformatics and next-generation sequencing has advanced the understanding of microbial communities in diverse ecosystems. Committed to mentorship and innovation, Dr. Ibrahim’s career reflects a dedication to advancing scientific knowledge and fostering international collaboration in microbiome science.

Conclusion

Dr. Khalid Subhi Ibrahim is a distinguished researcher with expertise in diagnostic and molecular microbiology, clinical biochemistry, and microbiome analysis. His extensive academic and professional journey reflects a strong commitment to advancing biomedical sciences, with a particular focus on gut microbiome research in relation to obesity, Type 2 diabetes, pollution, and colorectal cancer. Dr. Ibrahim’s collaborative projects with esteemed institutions, including MIT and the University of Tartu, underscore his global impact and research network. His proficiency in cutting-edge techniques such as next-generation sequencing, bioinformatics, and microbiota analysis highlights his technical expertise. Additionally, his dedication to knowledge dissemination through teaching, supervising, and publishing further solidifies his contributions to science. While Dr. Ibrahim’s focus on microbiome studies is commendable, expanding his publication record in high-impact journals would further strengthen his academic influence. Overall, Dr. Khalid Subhi Ibrahim demonstrates exceptional merit as a candidate for the Best Researcher Award.

Publications Top Noted

  1. Title: Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
    Authors: Naghavi, M., Ong, K.L., Aali, A., Wool, E.E., Murray, C.J.L.
    Year: 2024
    Citations: 259
  2. Title: Retrospective analysis of pediatric sepsis and the burden of antimicrobial resistance in Duhok, Kurdistan Region of Iraq
    Authors: Ibrahim, D.R., Saadi, A.T., Yahya, N.B., Alarsalani, B.K., Ibrahim, K.S.
    Year: 2024
    Citations: 0
  3. Title: Global Burden of Cardiovascular Diseases and Risks, 1990-2022
    Authors: Mensah, G.A., Habtegiorgis Abate, Y., Abbasian, M., Murray, C.J.L., Roth, G.A.
    Year: 2023
    Citations: 295
  4. Title: Chinese medicine, Qijudihuang pill, mediates cholesterol metabolism and regulates gut microbiota in high-fat diet-fed mice, implications for age-related macular degeneration
    Authors: Cao, Y., Ibrahim, K.S., Li, X., Craft, J.A., Shu, X.
    Year: 2023
    Citations: 0
  5. Title: Molecular Characterization of Extended Spectrum β-Lactamase (ESBL) and Virulence Gene-Factors in Uropathogenic Escherichia coli (UPEC) in Children in Duhok City, Kurdistan Region, Iraq
    Authors: Hasan, S.M., Ibrahim, K.S.
    Year: 2022
    Citations: 5
  6. Title: In silico analysis of bacterial metabolism of glutamate and GABA in the gut in a rat model of obesity and type 2 diabetes
    Authors: Ibrahim, K.S., Bourwis, N., Dolan, S., Craft, J.A.
    Year: 2022
    Citations: 2
  7. Title: Effect of a TSPO ligand on retinal pigment epithelial cholesterol homeostasis in high-fat fed mice, implication for age-related macular degeneration
    Authors: Biswas, L., Ibrahim, K.S., Li, X., Craft, J., Shu, X.
    Year: 2021
    Citations: 16
  8. Title: Transcriptome-wide changes associated with the reproductive behaviour of male guppies exposed to 17α-ethinyl estradiol
    Authors: Saaristo, M., Craft, J.A., Tyagi, S., Ibrahim, K.S., Wong, B.B.M.
    Year: 2021
    Citations: 8
  9. Title: Prevalence and Hemato-biochemical Studies on Theileriosis in Naturally Infected Cattle in Erbil Province
    Authors: Aziz, K., Qader, N., Ibrahim, K.
    Year: 2021
    Citations: 3
  10. Title: Etifoxine reverses weight gain and alters the colonic bacterial community in a mouse model of obesity
    Authors: Ibrahim, K.S., Craft, J.A., Biswas, L., Spencer, J., Shu, X.
    Year: 2020
    Citations: 15

 

 

Yuanyuan Li | Genetics and Molecular Biology | Best Researcher Award

Dr. Yuanyuan Li | Genetics and Molecular Biology | Best Researcher Award

Attending physician, Department of Endocrinology, Children’s Hospital of Nanjing Medical University, China.

Yuanyuan Li is a dedicated pediatrician and researcher with a Ph.D. in Clinical Medicine (Pediatrics) from Nanjing Medical University. Her research focuses on pediatric metabolic and kidney diseases, with particular interest in metabolic dysfunction-associated fatty liver disease. Li has published extensively as the first or corresponding author in prestigious journals, contributing valuable insights into liver disease, kidney dysfunction, and related metabolic conditions. She has led significant research projects funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Her clinical expertise is recognized through awards such as the Best Resident Physician Award and the Ruihua First-Class Scholarship from Nanjing Children’s Hospital. Li’s research holds the potential for a positive impact on pediatric healthcare, while her leadership in both clinical and research settings highlights her as a rising scholar in her field.

Profile:

Education

Yuanyuan Li has a solid educational foundation in Clinical Medicine, specializing in Pediatrics. She earned her Ph.D. in Clinical Medicine (Pediatrics) from Nanjing Medical University in 2020, under the supervision of Professor Zhanjun Jia. Her doctoral research focused on pediatric diseases, with a particular emphasis on metabolic and kidney disorders. Prior to her Ph.D., Li completed her Master of Science in Clinical Medicine (Pediatrics) at the same university in 2017, guided by Professor Aihua Zhang. During this time, she honed her clinical and research skills, gaining in-depth knowledge of pediatric healthcare. Li began her academic journey with a Bachelor of Science in Clinical Medicine (Pediatrics), which she completed in 2015. Her comprehensive education, grounded in both theoretical knowledge and practical experience, has equipped her with the expertise to conduct impactful research and provide specialized pediatric care, particularly in the fields of metabolism and kidney disease.

Professional Experience

Yuanyuan Li has extensive professional experience as a pediatrician at Nanjing Children’s Hospital, where she has been serving since October 2020. In this role, she is responsible for the specialized diagnosis and treatment of pediatric diseases, with a particular focus on metabolic and kidney-related conditions. Her clinical expertise is complemented by her active involvement in epidemiological research, where she investigates the occurrence of pediatric diseases and explores related pathogenesis. Li’s dedication to integrating clinical practice with research allows her to translate scientific findings into improved patient care. Additionally, she has led several research projects funded by prestigious institutions such as the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Her role as a project head in these research initiatives reflects her leadership abilities and commitment to advancing knowledge in the field of pediatric health, particularly in metabolic disorders and kidney diseases.

Research Interests

Yuanyuan Li’s research interests focus on pediatric metabolic and kidney diseases, with a particular emphasis on understanding metabolic dysfunction and its implications. Her work explores the characteristics and pathogenesis of metabolic dysfunction-associated fatty liver disease, delving into the intricate mechanisms that connect metabolic disorders with liver damage. Additionally, she investigates kidney diseases, studying conditions like acute kidney injury and renal fibrosis, especially in pediatric populations. Yuanyuan is also interested in oxidative stress and its role in metabolic and infectious diseases, examining how factors like birthweight influence disease development. Her research aims to uncover the molecular pathways involved in these conditions, with the ultimate goal of improving diagnosis, treatment, and prevention strategies. By combining clinical and basic research, she contributes to a deeper understanding of metabolic diseases, hoping to make a significant impact on pediatric healthcare and public health outcomes.

Award and Recognition

Yuanyuan Li has received multiple prestigious awards and recognitions throughout her academic and professional career. She was honored with the Best Resident Physician Award at Nanjing Children’s Hospital in 2021, a testament to her outstanding clinical expertise and dedication to pediatric care. That same year, she earned the Ruihua First-Class Scholarship, further acknowledging her academic excellence and commitment to research. Yuanyuan has led several significant research projects, including those funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation, highlighting her leadership and innovation in the field of metabolic and kidney diseases. Her numerous publications in high-impact journals solidify her reputation as an emerging leader in clinical and basic research. These accolades reflect not only her individual achievements but also her contribution to advancing pediatric medicine and metabolic disease research on a national and international level.

Conclusion

Yuanyuan Li’s academic achievements, research contributions, and clinical excellence position her as a strong contender for the Research for Best Scholar Award. Her focus on pediatric metabolic and kidney diseases addresses critical healthcare challenges, and her leadership in securing research funding demonstrates her potential for sustained scholarly impact. However, further development in international collaboration, mentorship, and research diversification could enhance her candidacy and future contributions to the academic community.

Publication Top Notes

    1. QbD-Based Stability-Indicating RP-HPLC Method Development and Validation for the Estimation of Favipiravir—An Eco-Friendly ApproachAuthors: Siri Chandana, M., Sujatha, K., Ajitha, A., Narendra, P., Sonia, K.

      Year: 2024

      Citation: Journal of AOAC International, 107(3), pp. 377–386. 🧪🌱

    2. An Overview of Pharmacological Activities and Beneficial Effects of 3-HydroxyflavoneAuthors: Ayyanna, C., Kuppusamy, S., Kumar, P.P.

      Year: 2024

      Citation: Macromolecular Symposia, 413(2), 2300078. 📚💊

    3. Analytical Quality by Design-Assisted HPLC Method for Quantification of Canagliflozin and Stability StudiesAuthors: Azhakesan, A., Kuppusamy, S.

      Year: 2023

      Citation: ACS Omega, 8(8), pp. 7407–7414. 🔍📈

    4. Development and Validation of UFLC-MS/MS Analytical Method for the Simultaneous Quantification of Antibiotic Residues in Surface Water, Groundwater, and Pharmaceutical Waste Water Samples from South IndiaAuthors: Kamatham, S., Seeralan, M., Sekar, U., Kuppusamy, S.

      Year: 2023

      Citation: ACS Omega. 🌊💧

    5. QbD-Based Development and Validation of Novel Stability-Indicating Method for the Assay and Dissolution of Garenoxacin in Garenoxacin TabletsAuthors: Azhakesan, A., Kuppusamy, S.

      Year: 2022

      Citation: Journal of AOAC International, 105(2), pp. 370–378. 📦💊

    6. Canagliflozin: A review with specific focus on analytical methods in biological matrices and pharmaceuticalsAuthors: Azhakesan, A., Kuppusamy, S.

      Year: 2022

      Citation: Reviews in Analytical Chemistry, 41(1), pp. 287–300. 🧬📖

    7. Formulation and Evaluation of Miglitol Matrix Tablets by Using Hibiscus Rosa Sinensis Leaves MucilageAuthors: Deepika, B., Sujatha, K., Thanga Thirupathi, A., Chamundeeswari, D.

      Year: 2021

      Citation: Research Journal of Pharmacy and Technology, 14(1), pp. 245–248. 🌺💊

    8. Bioanalytical Method Development and Validation for Simultaneous Estimation of Nitazoxanide and Ofloxacin in Human Plasma by RP-HPLCAuthors: Ajitha, A., Abbulu, K., Sujatha, K., Sireesha, P.

      Year: 2020

      Citation: Indian Drugs, 57(10), pp. 47–57. 💉🔬

    9. Bioanalytical Method Development and Validation of Garenoxacin Mesylate in Human Plasma by RP-HPLCAuthors: Ajitha, A., Sujatha, K., Abbulu, K.

      Year: 2019

      Citation: International Journal of Research in Pharmaceutical Sciences, 10(2), pp. 1314–1320. 🧪🩸

    10. The Identification of Bioactive Compounds from Turbinaria Ornata (Turner) J. Agaradh and Computational StudiesAuthors: Deepa, S., Sujatha, K., Velmurugan, D.

      Year: 2019

      Citation: Pharmacognosy Journal, 11(5), pp. 873–883. 🍃🔍

Paul Cullen | Genetics | Best Researcher Award

Dr. Paul Cullen | Genetics | Best Researcher Award

Doctorate at University at Buffalo, United States

Dr. Paul Cullen is a Professor in the Department of Biological Sciences at the University at Buffalo, specializing in molecular genetics and cell biology. He completed his postdoctoral training at the Institute of Molecular Biology at the University of Oregon, where he worked on MAP kinase (MAPK) signaling pathways, funded by grants from the American Heart Association and the National Institutes of Health (NIH). Dr. Cullen earned his Ph.D. in Molecular Genetics from Washington University in Saint Louis, where his research focused on bacterial nitrogen control proteins. He holds a Bachelor of Science in Biological Sciences from the University of Illinois at Urbana-Champaign, graduating Magna Cum Laude with Distinction. Dr. Cullen’s research interests revolve around understanding the regulation of cellular differentiation and signaling pathways, particularly in yeast. He has received numerous accolades, including the UB Exceptional Scholar’s Award and the Distinguished Postdoc Mentor Award. His work is supported by multiple NIH grants, and he has contributed significantly to the scientific community through publications and mentorship.

Education

Dr. Paul Cullen holds an impressive educational background in the field of biological sciences and molecular genetics. He earned his Bachelor of Science degree in Biological Sciences from the University of Illinois, Urbana-Champaign, graduating Magna Cum Laude with Distinction in 1990. His undergraduate thesis, titled “Effect of Ecdysone on In Vitro Pupal Wing Development in Lepidoptera,” was conducted under the supervision of Dr. Judith Willis and Dr. Johnathan Widom. Following this, Dr. Cullen pursued his Doctor of Philosophy (Ph.D.) in Molecular Genetics at Washington University, Saint Louis, completing his degree in 1997. His Ph.D. research, titled “Bacterial Nitrogen Control Proteins,” was guided by Dr. Robert G. Kranz. Additionally, from 1998 to 2004, Dr. Cullen completed postdoctoral training at the Institute of Molecular Biology at the University of Oregon, under the mentorship of Dr. George F. Sprague, Jr. His postdoctoral work was supported by prestigious grants from the American Heart Association and the National Institutes of Health (NIH), further solidifying his expertise in molecular biology.

Professional Experience

Dr. Paul Cullen has held a series of prestigious academic and research positions throughout his career. He is currently a Professor in the Department of Biological Sciences at the University at Buffalo, where he has been a faculty member since 2004. Prior to his promotion to Professor in 2017, Dr. Cullen served as an Associate Professor from 2010 to 2017 and as an Assistant Professor from 2004 to 2010. He has also held a joint appointment as Clinical Research Assistant Professor in the Department of Microbiology and Immunology since 2005. Earlier in his career, Dr. Cullen was a Senior Research Fellow at the Institute of Molecular Biology at the University of Oregon from 2000 to 2004. He has also contributed to scientific review panels, including serving as an NIH Review Panelist for Eukaryotic Pathogens in 2024. In addition to his research, Dr. Cullen has been deeply involved in academic administration, serving as the Director of Graduate Affairs for the Department of Biological Sciences from 2019 to 2024 and as a member of the Graduate School Executive Committee from 2023 to 2024.

Research Interest

Dr. Paul Cullen’s research interests focus on understanding the molecular mechanisms that regulate cellular differentiation, particularly through MAP kinase (MAPK) signaling pathways. His work explores how these pathways control cellular responses to environmental cues, with a special emphasis on the filamentous growth of Saccharomyces cerevisiae (yeast). Dr. Cullen investigates the role of cell polarity proteins in modulating MAPK signaling and how regulatory proteins influence these pathways. His research also extends to studying signal transduction in various biological systems, aiming to uncover broader implications for cellular behavior and development in eukaryotic organisms. Through his work, Dr. Cullen seeks to advance knowledge of genetic and molecular processes that underpin complex biological responses, contributing to the fields of molecular genetics, cell biology, and microbiology.

Research Skills

Dr. Paul Cullen possesses extensive research skills in molecular genetics and cell biology, particularly in the regulation of MAP kinase (MAPK) signaling pathways. His expertise includes advanced molecular techniques such as gene manipulation, protein-protein interaction studies, and genetic screening in model organisms like Saccharomyces cerevisiae. Dr. Cullen is skilled in using molecular and genetic tools to investigate cellular differentiation, signal transduction, and environmental response mechanisms. He has a strong background in high-throughput screening, microscopy, and quantitative data analysis. His research also involves cutting-edge technologies in genetic sequencing, bioinformatics, and structural biology, contributing to his deep understanding of cellular signaling networks and their implications for health and disease.

Award and Recognition

Dr. Paul Cullen has received numerous accolades for his exemplary contributions to research and education. In 2023, he was honored with the UB Exceptional Scholar’s Award for Sustained Achievement and the UB Graduate School Distinguished Postdoc Mentor Award, recognizing his significant impact in mentorship. Additionally, he received the Milton Plesur Excellence in Teaching Award in 2008 for his dedication to student learning. His active membership in professional organizations such as the American Society of Cell Biology and the American Society of Microbiology further highlights his commitment to advancing the field of molecular biology.

Conclusion

Dr. Paul Cullen’s remarkable achievements in molecular biology, sustained research contributions, and commitment to mentoring make him a distinguished figure in his field. His combination of academic excellence, leadership, and impactful research positions him as an exemplary candidate for the “Research for Best Researcher Award.”

Publication Top Notes

  • “Glucose depletion causes haploid invasive growth in yeast”
    • Journal: Proceedings of the National Academy of Sciences
    • Cited by: 444
    • Year: 2000
    • Volume: 97, Issue 25
    • Pages: 13619-13624
  • “The regulation of filamentous growth in yeast”
    • Journal: Genetics
    • Cited by: 348
    • Year: 2012
    • Volume: 190, Issue 1
    • Pages: 23-49
  • “A signaling mucin at the head of the Cdc42-and MAPK-dependent filamentous growth pathway in yeast”
    • Journal: Genes & Development
    • Cited by: 268
    • Year: 2004
    • Volume: 18, Issue 14
    • Pages: 1695-1708
  • “GTPase-activating proteins for Cdc42”
    • Journal: Eukaryotic Cell
    • Cited by: 170
    • Year: 2002
    • Volume: 1, Issue 3
    • Pages: 469-480
  • “Defects in Protein Glycosylation Cause SHO1-Dependent Activation of a STE12 Signaling Pathway in Yeast”
    • Journal: Genetics
    • Cited by: 147
    • Year: 2000
    • Volume: 155, Issue 3
    • Pages: 1005-1018
  • “Cleavage of the signaling mucin Msb2 by the aspartyl protease Yps1 is required for MAPK activation in yeast”
    • Journal: The Journal of Cell Biology
    • Cited by: 144
    • Year: 2008
    • Volume: 181, Issue 7
    • Pages: 1073-1081
  • “Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1 MAPK signaling affecting biofilm formation and oropharyngeal candidiasis”
    • Journal: PLoS One
    • Cited by: 112
    • Year: 2012
    • Volume: 7, Issue 11
    • Pages: e46020
  • “Candida albicans biofilm development is governed by cooperative attachment and adhesion maintenance proteins”
    • Journal: NPJ Biofilms and Microbiomes
    • Cited by: 111
    • Year: 2019
    • Volume: 5, Issue 1
    • Pages: 21